Advertisement

Topics

Coverage Initiated on Synthetic Cannabinoid Bioscience Company, an 'Exciting, Undiscovered Story'

02:00 EDT 30 Jun 2017 | InvestorIdeas

June 30, 2017 (Investorideas.com Newswire) Laidlaw & Company initiated coverage on a company that is repurposing an approved cannabinoid to fulfill unmet medical needs.

Original Article: Coverage Initiated on Synthetic Cannabinoid Bioscience Company, an 'Exciting, Undiscovered Story'

NEXT ARTICLE

More From BioPortfolio on "Coverage Initiated on Synthetic Cannabinoid Bioscience Company, an 'Exciting, Undiscovered Story'"

Advertisement
Quick Search
Advertisement
Advertisement